Alisa Jane Stephens, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pelvic Pain | 8 | 2020 | 292 | 0.950 |
Why?
|
Urologic Diseases | 4 | 2020 | 247 | 0.490 |
Why?
|
Data Interpretation, Statistical | 3 | 2016 | 2689 | 0.440 |
Why?
|
Cystitis, Interstitial | 4 | 2019 | 66 | 0.430 |
Why?
|
Condoms | 1 | 2015 | 330 | 0.430 |
Why?
|
Models, Statistical | 3 | 2016 | 5073 | 0.350 |
Why?
|
Urinary Tract | 3 | 2019 | 313 | 0.330 |
Why?
|
Cluster Analysis | 2 | 2016 | 2700 | 0.320 |
Why?
|
Risk Reduction Behavior | 1 | 2015 | 1110 | 0.310 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2016 | 10199 | 0.300 |
Why?
|
Homosexuality, Male | 1 | 2015 | 1333 | 0.280 |
Why?
|
Prostatitis | 2 | 2015 | 102 | 0.230 |
Why?
|
Health Promotion | 1 | 2015 | 2206 | 0.210 |
Why?
|
Herpes Genitalis | 1 | 2023 | 149 | 0.200 |
Why?
|
Multivariate Analysis | 1 | 2014 | 12043 | 0.170 |
Why?
|
DNA, Fungal | 1 | 2019 | 275 | 0.150 |
Why?
|
Syndrome | 6 | 2020 | 3268 | 0.140 |
Why?
|
Fungi | 1 | 2019 | 338 | 0.130 |
Why?
|
Safe Sex | 1 | 2015 | 144 | 0.120 |
Why?
|
Vaccines | 1 | 2023 | 838 | 0.120 |
Why?
|
Negotiating | 1 | 2015 | 150 | 0.110 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2017 | 632 | 0.110 |
Why?
|
Catastrophization | 1 | 2017 | 348 | 0.110 |
Why?
|
HIV Infections | 3 | 2016 | 17337 | 0.100 |
Why?
|
HIV Protease Inhibitors | 1 | 2014 | 432 | 0.090 |
Why?
|
Computer Simulation | 3 | 2016 | 6233 | 0.090 |
Why?
|
Models, Psychological | 1 | 2015 | 829 | 0.090 |
Why?
|
Sexual Partners | 1 | 2015 | 800 | 0.090 |
Why?
|
Arachidonic Acid | 1 | 2011 | 427 | 0.080 |
Why?
|
Risk-Taking | 1 | 2015 | 1037 | 0.080 |
Why?
|
Treatment Outcome | 3 | 2016 | 64568 | 0.080 |
Why?
|
Severity of Illness Index | 5 | 2018 | 15828 | 0.080 |
Why?
|
CD4 Lymphocyte Count | 1 | 2014 | 2567 | 0.070 |
Why?
|
Behavior Therapy | 1 | 2012 | 877 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2017 | 3492 | 0.060 |
Why?
|
Sexual Behavior | 1 | 2015 | 2187 | 0.060 |
Why?
|
Nerve Net | 1 | 2017 | 2290 | 0.060 |
Why?
|
Docosahexaenoic Acids | 1 | 2011 | 907 | 0.060 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2014 | 1080 | 0.060 |
Why?
|
Bacteria | 1 | 2015 | 2192 | 0.060 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2012 | 2197 | 0.050 |
Why?
|
Urinalysis | 2 | 2015 | 368 | 0.050 |
Why?
|
Genitalia | 1 | 2023 | 113 | 0.050 |
Why?
|
Herpesvirus 2, Human | 1 | 2023 | 191 | 0.050 |
Why?
|
Infant, Premature | 1 | 2011 | 2107 | 0.050 |
Why?
|
Guinea Pigs | 1 | 2023 | 1310 | 0.050 |
Why?
|
Lung Diseases | 1 | 2011 | 1909 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2015 | 4007 | 0.040 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39063 | 0.040 |
Why?
|
Disease Progression | 1 | 2017 | 13495 | 0.040 |
Why?
|
Interdisciplinary Communication | 2 | 2017 | 928 | 0.040 |
Why?
|
Viral Envelope Proteins | 1 | 2023 | 640 | 0.040 |
Why?
|
Mental Disorders | 1 | 2018 | 6826 | 0.040 |
Why?
|
Adult | 10 | 2019 | 220969 | 0.040 |
Why?
|
Stress, Psychological | 1 | 2014 | 4488 | 0.040 |
Why?
|
Adjuvants, Immunologic | 1 | 2023 | 990 | 0.040 |
Why?
|
Humans | 17 | 2020 | 760617 | 0.040 |
Why?
|
Pain Measurement | 2 | 2018 | 3546 | 0.040 |
Why?
|
Longitudinal Studies | 3 | 2020 | 14591 | 0.040 |
Why?
|
Postal Service | 1 | 2017 | 96 | 0.030 |
Why?
|
Male | 12 | 2020 | 360358 | 0.030 |
Why?
|
Time Factors | 4 | 2019 | 39913 | 0.030 |
Why?
|
Female | 13 | 2023 | 392148 | 0.030 |
Why?
|
Psychological Tests | 1 | 2017 | 639 | 0.030 |
Why?
|
Young Adult | 3 | 2015 | 59179 | 0.030 |
Why?
|
Alberta | 1 | 2014 | 68 | 0.030 |
Why?
|
Urine | 1 | 2015 | 362 | 0.030 |
Why?
|
United States | 3 | 2017 | 72272 | 0.030 |
Why?
|
Antibodies, Neutralizing | 1 | 2023 | 1936 | 0.030 |
Why?
|
Rest | 1 | 2017 | 918 | 0.030 |
Why?
|
Sex Factors | 2 | 2017 | 10548 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2023 | 3150 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2023 | 3461 | 0.020 |
Why?
|
Biomedical Research | 2 | 2017 | 3426 | 0.020 |
Why?
|
Brain | 1 | 2017 | 27101 | 0.020 |
Why?
|
Actigraphy | 1 | 2014 | 521 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3800 | 0.020 |
Why?
|
Phenotype | 2 | 2019 | 16571 | 0.020 |
Why?
|
DNA | 1 | 2023 | 7196 | 0.020 |
Why?
|
Prospective Studies | 3 | 2019 | 54360 | 0.020 |
Why?
|
Chronic Disease | 2 | 2014 | 9311 | 0.020 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2011 | 410 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2014 | 3410 | 0.020 |
Why?
|
Psychometrics | 1 | 2017 | 3060 | 0.020 |
Why?
|
Retinopathy of Prematurity | 1 | 2011 | 439 | 0.020 |
Why?
|
Affect | 1 | 2014 | 1486 | 0.020 |
Why?
|
Self Report | 1 | 2017 | 3723 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2018 | 26049 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2015 | 58894 | 0.020 |
Why?
|
Middle Aged | 5 | 2018 | 220584 | 0.010 |
Why?
|
Neoplasms | 1 | 2014 | 22131 | 0.010 |
Why?
|
Risk | 1 | 2016 | 9604 | 0.010 |
Why?
|
Child | 1 | 2012 | 80079 | 0.010 |
Why?
|
Adolescent | 1 | 2012 | 88234 | 0.010 |
Why?
|
Fatty Acids | 1 | 2011 | 1808 | 0.010 |
Why?
|
Anxiety | 1 | 2017 | 4570 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 14648 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 13347 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 6174 | 0.010 |
Why?
|
Comorbidity | 1 | 2014 | 10505 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2017 | 20074 | 0.010 |
Why?
|
Sleep | 1 | 2014 | 4758 | 0.010 |
Why?
|
Aged | 3 | 2015 | 169042 | 0.010 |
Why?
|
Depression | 1 | 2017 | 8132 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2015 | 22148 | 0.010 |
Why?
|
Sepsis | 1 | 2011 | 2585 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2011 | 12447 | 0.010 |
Why?
|
Prognosis | 1 | 2017 | 29600 | 0.010 |
Why?
|
Animals | 1 | 2023 | 168201 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2011 | 26180 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 36402 | 0.010 |
Why?
|
Cohort Studies | 1 | 2011 | 41457 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2011 | 80566 | 0.000 |
Why?
|